Santiago Garza | Universidad Antonio Nariño (original) (raw)
Papers by Santiago Garza
Rev Mex Ortop Traumatol, Jun 1, 2000
Journal of Electrical Chemistry, 1947
Page 1. ELECTRICALLY ACTIVATED ERGOSTEROL (WHITTIER PROCESS) BY WALDEMAR DASLER AND CLIFFORD D. B... more Page 1. ELECTRICALLY ACTIVATED ERGOSTEROL (WHITTIER PROCESS) BY WALDEMAR DASLER AND CLIFFORD D. BAUER (From the Nutrition Research Laboratoiies, Chicago) (Received for publication, November 1, 1946) ...
Archives of Pediatrics & Adolescent Medicine, 1958
Page 1. Blood Plasma Pepsinogen in Acute Infections in Infants and Children HAROLD G. GRAYZEL, MD... more Page 1. Blood Plasma Pepsinogen in Acute Infections in Infants and Children HAROLD G. GRAYZEL, MD; BRUNO ELKAN, BS; ALENDRY P. CAVILES, MD; LAWRENCE SCHNECK, MD, and SANTIAGO L. GARZA, MD, Brooklyn ...
Archives of Pediatrics & Adolescent Medicine, 1958
The study was divided into two parts. One pertained to the determination of blood plasma pepsinog... more The study was divided into two parts. One pertained to the determination of blood plasma pepsinogen levels in normal infants and children; the other, to urine pepsinogen (uropepsin) ex-cretion values. Only children free of acute or chronic disease, malignancy, or involvement of the ...
Handbook of clinical neurology, 2014
Neurologic complications of conventional cytototxic agents as well as those from monoclonal antib... more Neurologic complications of conventional cytototxic agents as well as those from monoclonal antibodies and targeted therapies are increasingly observed in patients with cancer. The major categories are represented by alkylating agents (platinum compounds, ifosfamide, procarbazine, thiotepa), mitotic spindle inhibitors (vinca alkaloids, taxanes, etoposide, teniposide), proteasome inhibitors (bortezomib), antibiotics, antimetabolites, thalidomide, lenalidomide, topoisomerase inhibitors, interferon-α, hormones, bevacizumab, trastuzumab, and small tyrosine kinase inhibitors. Peripheral neuropathy is a common adverse effect of a number of chemotherapeutic drugs and often represents a critical factor limiting an adequate dose-intensity of chemotherapy. Regarding the central nervous system (CNS), it is vulnerable to many forms of toxicity from chemotherapeutic agents, including encephalopathy syndromes and confusional states, seizures, headache, cerebrovascular complications, visual loss, ...
Rev Mex Ortop Traumatol, Jun 1, 2000
Journal of Electrical Chemistry, 1947
Page 1. ELECTRICALLY ACTIVATED ERGOSTEROL (WHITTIER PROCESS) BY WALDEMAR DASLER AND CLIFFORD D. B... more Page 1. ELECTRICALLY ACTIVATED ERGOSTEROL (WHITTIER PROCESS) BY WALDEMAR DASLER AND CLIFFORD D. BAUER (From the Nutrition Research Laboratoiies, Chicago) (Received for publication, November 1, 1946) ...
Archives of Pediatrics & Adolescent Medicine, 1958
Page 1. Blood Plasma Pepsinogen in Acute Infections in Infants and Children HAROLD G. GRAYZEL, MD... more Page 1. Blood Plasma Pepsinogen in Acute Infections in Infants and Children HAROLD G. GRAYZEL, MD; BRUNO ELKAN, BS; ALENDRY P. CAVILES, MD; LAWRENCE SCHNECK, MD, and SANTIAGO L. GARZA, MD, Brooklyn ...
Archives of Pediatrics & Adolescent Medicine, 1958
The study was divided into two parts. One pertained to the determination of blood plasma pepsinog... more The study was divided into two parts. One pertained to the determination of blood plasma pepsinogen levels in normal infants and children; the other, to urine pepsinogen (uropepsin) ex-cretion values. Only children free of acute or chronic disease, malignancy, or involvement of the ...
Handbook of clinical neurology, 2014
Neurologic complications of conventional cytototxic agents as well as those from monoclonal antib... more Neurologic complications of conventional cytototxic agents as well as those from monoclonal antibodies and targeted therapies are increasingly observed in patients with cancer. The major categories are represented by alkylating agents (platinum compounds, ifosfamide, procarbazine, thiotepa), mitotic spindle inhibitors (vinca alkaloids, taxanes, etoposide, teniposide), proteasome inhibitors (bortezomib), antibiotics, antimetabolites, thalidomide, lenalidomide, topoisomerase inhibitors, interferon-α, hormones, bevacizumab, trastuzumab, and small tyrosine kinase inhibitors. Peripheral neuropathy is a common adverse effect of a number of chemotherapeutic drugs and often represents a critical factor limiting an adequate dose-intensity of chemotherapy. Regarding the central nervous system (CNS), it is vulnerable to many forms of toxicity from chemotherapeutic agents, including encephalopathy syndromes and confusional states, seizures, headache, cerebrovascular complications, visual loss, ...